VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $193,712 | +8749.3% | 62,690 | -84.6% | 0.00% | -100.0% |
| Q1 2023 | $2,189 | -33.9% | 406,851 | -18.3% | 0.00% | -50.0% |
| Q4 2022 | $3,312 | -99.8% | 498,080 | +47.0% | 0.00% | +100.0% |
| Q3 2022 | $1,349,000 | -6.1% | 338,921 | +17.3% | 0.00% | 0.0% |
| Q2 2022 | $1,436,000 | +1336.0% | 288,942 | +1639.3% | 0.00% | – |
| Q1 2022 | $100,000 | -70.8% | 16,613 | -9.4% | 0.00% | – |
| Q2 2021 | $342,000 | – | 18,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |